Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Tesamorelin Acetate (EGRIFTA) — The Complete History

The history and science of Tesamorelin Acetate (EGRIFTA). From discovery in 1995 to modern research — pioneers, breakthroughs, and clinical impact.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

1996-2000

The Hidden Cost of Survival

When the Cure Changed Your Body

Key Moment

Life-saving HIV drugs caused disfiguring fat redistribution

In 1996, the AIDS crisis turned a corner. New combination drug therapies — the famous 'cocktails' — were saving lives. People who had been planning their funerals were suddenly planning their futures.

But the drugs came with a price. Within months of starting treatment, many patients noticed something strange. Fat was disappearing from their faces, arms, and legs, but piling up around their bellies. Their cheeks became hollow. Their limbs looked skeletal. But their abdomens swelled.

Doctors called it lipodystrophy — a fancy word for 'fat in the wrong places.' Patients called it something worse: 'Crix belly,' named after Crixivan, one of the drugs that seemed to cause it. They had survived AIDS only to look like they were still dying.

Connected topics

Follow this recovery question